{"id":"https://openalex.org/W2969942737","doi":"https://doi.org/10.1186/s12951-019-0519-6","title":"Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides","display_name":"Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides","publication_year":2019,"publication_date":"2019-08-19","ids":{"openalex":"https://openalex.org/W2969942737","doi":"https://doi.org/10.1186/s12951-019-0519-6","mag":"2969942737","pmid":"https://pubmed.ncbi.nlm.nih.gov/31426807","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6699136"},"language":"en","primary_location":{"id":"doi:10.1186/s12951-019-0519-6","doi":"https://doi.org/10.1186/s12951-019-0519-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12951-019-0519-6","pdf_url":"https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-019-0519-6","source":{"id":"https://openalex.org/S41231013","display_name":"Journal of Nanobiotechnology","issn_l":"1477-3155","issn":["1477-3155"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nanobiotechnology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-019-0519-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069012936","display_name":"Shu-Ting Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Shu-Ting Hong","raw_affiliation_strings":["Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082740187","display_name":"Hua\u2010Ching Lin","orcid":"https://orcid.org/0000-0003-3958-3760","observed_orcids":["https://orcid.org/0000-0003-3958-3760"]},"institutions":[{"id":"https://openalex.org/I4210101378","display_name":"Cheng Hsin General Hospital","ror":"https://ror.org/014f77s28","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210101378"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Huaching Lin","raw_affiliation_strings":["Division of Colorectal Surgery, Cheng Hsin General Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Colorectal Surgery, Cheng Hsin General Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210101378"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030839793","display_name":"Chen-Shen Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chen-Shen Wang","raw_affiliation_strings":["Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112652076","display_name":"Chih-Hsien Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Chih-Hsien Chang","raw_affiliation_strings":["Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102107253","display_name":"Anya Maan-Yuh Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]},{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Anya Maan-Yuh Lin","raw_affiliation_strings":["Department of Medical Research, Taipei Veterans General Hospital, Taipei, 112, Taiwan","Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan","Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Research, Taipei Veterans General Hospital, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I2803004286"]},{"raw_affiliation_string":"Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]},{"raw_affiliation_string":"Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I16733864","display_name":"National Taiwan University","ror":"https://ror.org/05bqach95","country_code":"TW","type":"education","lineage":["https://openalex.org/I16733864"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":["Institute of Oncology, National Taiwan University, Taipei, 106, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology, National Taiwan University, Taipei, 106, Taiwan","institution_ids":["https://openalex.org/I16733864"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010147133","display_name":"Yu\u2010Li Lo","orcid":"https://orcid.org/0000-0002-6548-3280","observed_orcids":["https://orcid.org/0000-0002-6548-3280"]},"institutions":[{"id":"https://openalex.org/I4387156312","display_name":"National Yang Ming University","ror":"https://ror.org/009h5ks85","country_code":"TW","type":"education","lineage":["https://openalex.org/I148366613","https://openalex.org/I4387156312"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Yu-Li Lo","raw_affiliation_strings":["Center for Advanced Pharmaceutics and Drug Delivery Research, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan"],"raw_orcid":"https://orcid.org/0000-0002-6548-3280","affiliations":[{"raw_affiliation_string":"Center for Advanced Pharmaceutics and Drug Delivery Research, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","institution_ids":["https://openalex.org/I4387156312"]},{"raw_affiliation_string":"Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","institution_ids":["https://openalex.org/I4387156312"]},{"raw_affiliation_string":"Institute of Pharmacology, National Yang-Ming University, Taipei, 112, Taiwan. yulilo@ym.edu.tw","institution_ids":["https://openalex.org/I4387156312"]},{"raw_affiliation_string":"Faculty of Pharmacy, National Yang-Ming University, Taipei, 112, Taiwan","institution_ids":["https://openalex.org/I4387156312"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010147133"],"corresponding_institution_ids":["https://openalex.org/I4387156312"],"apc_list":{"value":2680,"currency":"USD","value_usd":2680},"apc_paid":{"value":2680,"currency":"USD","value_usd":2680},"fwci":1.9115,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.8421126,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"17","issue":"1","first_page":"89","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mir-139","display_name":"miR-139","score":0.9449999928474426},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/core-shell-nanoparticles","display_name":"core-shell nanoparticles","score":0.7350000143051147},{"id":"https://openalex.org/keywords/ph-responsive-drug-release","display_name":"pH-responsive drug release","score":0.7450000047683716},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7149999737739563},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7950000166893005},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9409999847412109},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7239999771118164},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6380000114440918},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8679999709129333},{"id":"https://openalex.org/keywords/caco-2-cells","display_name":"Caco-2 cells","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.8945090770721436},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6259270310401917},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5684983730316162},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5551396608352661},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4568122625350952},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4309067726135254},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2841798961162567},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2601955533027649},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25799816846847534},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.22872263193130493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.195465087890625},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08917143940925598}],"mesh":[{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12951-019-0519-6","doi":"https://doi.org/10.1186/s12951-019-0519-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12951-019-0519-6","pdf_url":"https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-019-0519-6","source":{"id":"https://openalex.org/S41231013","display_name":"Journal of Nanobiotechnology","issn_l":"1477-3155","issn":["1477-3155"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nanobiotechnology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6699136","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6699136","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Nanobiotechnology","raw_type":"Text"},{"id":"pmid:31426807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31426807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nanobiotechnology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:fd10b71ae5534e21b3c64395d04e1c5b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/fd10b71ae5534e21b3c64395d04e1c5b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nanobiotechnology, Vol 17, Iss 1, Pp 1-20 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12951-019-0519-6","doi":"https://doi.org/10.1186/s12951-019-0519-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12951-019-0519-6","pdf_url":"https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-019-0519-6","source":{"id":"https://openalex.org/S41231013","display_name":"Journal of Nanobiotechnology","issn_l":"1477-3155","issn":["1477-3155"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Nanobiotechnology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2096943222","display_name":"The Development of Dual-Responsive and Tumor-Targeting Nanoparticles for Delivery of Chemotherapy and Crispr/Cas System","funder_award_id":"MOST107-2320-B010-015-MY3","funder_id":"https://openalex.org/F4320322795","funder_display_name":"Ministry of Science and Technology, Taiwan"},{"id":"https://openalex.org/G497937365","display_name":null,"funder_award_id":"MOST 107?","funder_id":"https://openalex.org/F4320322795","funder_display_name":"Ministry of Science and Technology, Taiwan"},{"id":"https://openalex.org/G532193189","display_name":null,"funder_award_id":"MOST 106-2320-B-010-005; MOST 107-2320-B-010-015-MY3","funder_id":"https://openalex.org/F4320322795","funder_display_name":"Ministry of Science and Technology, Taiwan"},{"id":"https://openalex.org/G8857269716","display_name":"Peptide-Modified and Ph-Responsive Lipid-Polymer Nanoparticles Encapsulating Anticancer Drugs and Microrna for Inhibition of Colorectal Cancer","funder_award_id":"MOST106-2320-B010-005","funder_id":"https://openalex.org/F4320322795","funder_display_name":"Ministry of Science and Technology, Taiwan"},{"id":"https://openalex.org/G939887807","display_name":null,"funder_award_id":"MOST 106","funder_id":"https://openalex.org/F4320322795","funder_display_name":"Ministry of Science and Technology, Taiwan"}],"funders":[{"id":"https://openalex.org/F4320322795","display_name":"Ministry of Science and Technology, Taiwan","ror":"https://ror.org/02kv4zf79"},{"id":"https://openalex.org/F4320323275","display_name":"National Yang-Ming University","ror":"https://ror.org/009h5ks85"},{"id":"https://openalex.org/F4320323440","display_name":"University System of Taiwan","ror":"https://ror.org/054kvr030"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2969942737.pdf","grobid_xml":"https://content.openalex.org/works/W2969942737.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1518693320","https://openalex.org/W1809622011","https://openalex.org/W1891799992","https://openalex.org/W1989658253","https://openalex.org/W1990010967","https://openalex.org/W1995577291","https://openalex.org/W1996801596","https://openalex.org/W2009259358","https://openalex.org/W2010105352","https://openalex.org/W2010976109","https://openalex.org/W2013262011","https://openalex.org/W2017661973","https://openalex.org/W2043481243","https://openalex.org/W2057337576","https://openalex.org/W2061149206","https://openalex.org/W2064156059","https://openalex.org/W2064742557","https://openalex.org/W2070803838","https://openalex.org/W2072554913","https://openalex.org/W2075446507","https://openalex.org/W2075716142","https://openalex.org/W2088833308","https://openalex.org/W2100621506","https://openalex.org/W2116508133","https://openalex.org/W2120921373","https://openalex.org/W2121697185","https://openalex.org/W2128707581","https://openalex.org/W2131592861","https://openalex.org/W2132870547","https://openalex.org/W2133190342","https://openalex.org/W2146437683","https://openalex.org/W2267242658","https://openalex.org/W2273625236","https://openalex.org/W2299957244","https://openalex.org/W2302003756","https://openalex.org/W2305144260","https://openalex.org/W2314550121","https://openalex.org/W2346732397","https://openalex.org/W2409189950","https://openalex.org/W2514277579","https://openalex.org/W2597190528","https://openalex.org/W2618974892","https://openalex.org/W2623330298","https://openalex.org/W2729023252","https://openalex.org/W2767200425","https://openalex.org/W2789380726","https://openalex.org/W2792642508","https://openalex.org/W2891141728","https://openalex.org/W2902318318","https://openalex.org/W2918434565","https://openalex.org/W2929297688","https://openalex.org/W2939690596","https://openalex.org/W2944684880"],"related_works":["https://openalex.org/W2988746134","https://openalex.org/W3009327364","https://openalex.org/W4404682979","https://openalex.org/W4313898620","https://openalex.org/W3108938212","https://openalex.org/W6902449969","https://openalex.org/W7214388928","https://openalex.org/W2965073335","https://openalex.org/W2549823470","https://openalex.org/W4413377525"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,27,66,162],"emergence":[2],"of":[3,46,63,68,97,106,135,174,216,231,236,253,260],"resistance":[4,230],"to":[5,86,110,130,184,198,256,264],"chemotherapy":[6],"or":[7,113],"target":[8],"therapy,":[9],"tumor":[10,53],"metastasis,":[11,92],"and":[12,43,48,56,93,125,158,170,193,218,226,229],"systemic":[13],"toxicity":[14,197],"caused":[15],"by":[16,118],"available":[17],"anticancer":[18,133],"drugs":[19],"hamper":[20],"the":[21,132,185,214,258],"successful":[22],"colorectal":[23,178],"cancer":[24,262],"(CRC)":[25],"treatment.":[26],"rise":[28],"in":[29,60,182,220],"epidermal":[30,36],"growth":[31,37],"factor":[32,38],"receptor":[33,39],"(EGFR;":[34],"human":[35,177],"1;":[40],"HER1)":[41],"expression":[42],"enhanced":[44,172],"phosphorylation":[45],"HER2":[47],"HER3":[49],"are":[50],"associated":[51],"with":[52,90,121,151],"resistance,":[54],"metastasis":[55],"invasion,":[57],"thus":[58],"resulting":[59],"poor":[61],"outcome":[62],"anti-CRC":[64],"therapy.":[65],"use":[67],"afatinib,":[69],"a":[70,74,102,107,122,126,148,166,203,246],"pan-HER":[71,237],"inhibitor,":[72],"is":[73,116],"potential":[75],"therapeutic":[76],"approach":[77],"for":[78,250],"resistant":[79],"CRC.":[80,98],"Additionally,":[81],"miR-139":[82,194,219],"has":[83],"been":[84],"reported":[85],"be":[87],"negatively":[88],"correlated":[89],"chemoresistance,":[91],"epithelial-mesenchymal":[94],"transition":[95],"(EMT)":[96],"Hence,":[99],"we":[100],"develop":[101],"nanoparticle":[103,189,248],"formulation":[104,146,190,249],"consisting":[105],"polymer":[108],"core":[109],"carry":[111],"afatinib":[112,192,217],"miR-139,":[114],"which":[115],"surrounded":[117],"lipids":[119],"modified":[120],"targeting":[123],"ligand":[124],"pH-sensitive":[127,167],"penetrating":[128],"peptide":[129],"improve":[131],"effect":[134,206],"cargos":[136,175],"against":[137],"CRC":[138],"cells.":[139],"RESULTS:":[140],"Our":[141],"findings":[142],"show":[143],"that":[144],"this":[145],"displays":[147],"spherical":[149],"shape":[150],"core/shell":[152],"structure,":[153],"homogeneous":[154],"particle":[155],"size":[156],"distribution":[157],"negative":[159],"zeta":[160],"potential.":[161],"prepared":[163],"formulations":[164],"demonstrate":[165],"release":[168],"profile":[169],"an":[171],"uptake":[173],"into":[176],"adenocarcinoma":[179],"Caco-2":[180,208,232],"cells":[181,200,209,233,263],"response":[183],"acidic":[186],"pH.":[187],"This":[188,243],"incorporating":[191],"exhibits":[195],"low":[196],"normal":[199],"but":[201],"shows":[202],"better":[204],"inhibitory":[205],"on":[207],"than":[210],"other":[211],"formulations.":[212],"Moreover,":[213],"encapsulation":[215],"peptide-modified":[221],"nanoparticles":[222],"remarkably":[223],"induces":[224],"apoptosis":[225],"inhibits":[227],"migration":[228],"via":[234],"suppression":[235],"tyrosine":[238],"kinase/multidrug":[239],"resistance/metastasis":[240],"pathways.":[241],"CONCLUSION:":[242],"study":[244],"proposes":[245],"multifunctional":[247],"targeted":[251],"modulation":[252],"apoptosis/EGFR/HER/EMT/resistance/progression":[254],"pathways":[255],"increase":[257],"sensitivity":[259],"colon":[261],"afatinib.":[265]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-08-29T00:00:00"}